Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02065466
Title Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Arizona
Indications

melanoma

Therapies

Bevacizumab + Nab-paclitaxel + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.